Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.96
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
6.96
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $445.55 million as of April 28, 2026. Its market cap has increased by 78.49% in one year.
Market Cap
445.55M
Enterprise Value
314.19M
1-Year Change
78.49%
Ranking
Category
Stock Price
$6.96
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $445.55M, an increase of 12.02%. That is a compound annual growth rate of 2.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 446.83M | 29.11% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 466.56M |
| Ovid Therapeutics | 465.47M |
| Larimar Therapeutics | 461.24M |
| Candel Therapeutics | 460.72M |
| Ginkgo Bioworks Holdings | 455.18M |
| Prelude Therapeutics | 454.50M |
| Climb Bio | 453.80M |
| Eupraxia Pharmaceuticals | 445.74M |